VU-6036720

N/A

Report date: 2026/01/12 17:55:30
NME

Base Information

Drug NameVU-6036720
Drug Alias NameVU-6036720
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionATP-sensitive inward rectifier potassium channel 10 inhibitorsInward rectifier potassium channel 16 inhibitors
TargetsATP-sensitive inward rectifier potassium channel 10Inward rectifier potassium channel 16
Therapy Area/IndicationsEdemaHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVanderbilt University
China Registration ClassN/A

Develop Information

Active CompaniesVanderbilt University
Inactive CompaniesN/A
Active IndicationsEdemaHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A